INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, published by Wiley, is a leading peer-reviewed journal dedicated to the field of experimental pathology. With an ISSN of 0959-9673 and E-ISSN 1365-2613, the journal has been a vital resource for researchers and professionals since its inception in 1990, covering a broad spectrum of topics within pathology, cell biology, and molecular biology. The journal's relevancy is underscored by its Q2 ranking in Pathology and Forensic Medicine and Q3 rankings in both Cell Biology and Molecular Biology, as of 2023, reflecting its significant contribution to the scientific community. Although it does not currently offer open access options, readers can benefit from its insightful research articles and reviews that guide advancements in diagnostic pathology and therapeutic strategies. As the journal continues to evolve, it remains committed to facilitating the exchange of innovative ideas and findings that drive progress in experimental pathology and related fields, making it an indispensable platform for scientists, clinicians, and students alike.

BioMedicine-Taiwan, published by DIGITAL COMMONS BEPRESS, stands as a prominent open-access journal that has been disseminating vital research since 2014. With an ISSN of 2211-8020 and E-ISSN 2211-8039, this journal covers a wide array of disciplines within the biomedical field, reaching researchers and professionals keen on exploring cutting-edge advancements and innovative approaches in biochemistry, genetics, and general medicine. Notably categorized as Q2 in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine for 2023, BioMedicine-Taiwan ranks well in its respective fields, reflecting its commitment to enhancing scholarly communication and knowledge dissemination. Situated in Taiwan, its impact is further highlighted by its Scopus rankings—placing it in the 70th percentile for general medicine and 47th percentile for general biochemistry and molecular biology, showcasing its significance in ongoing biomedical discourse. Researchers, students, and professionals are invited to engage with this invaluable resource to explore the latest findings and developments that shape the future of healthcare and biological sciences.

Translational Cancer Research, published by AME Publishing Company in Hong Kong, is a pivotal journal aimed at fostering the advancement of oncology-related knowledge through the dissemination of high-quality research findings. With its ISSN 2218-676X and E-ISSN 2219-6803, this journal serves as a vital resource for researchers, professionals, and students in the fields of Cancer Research, Oncology, and Radiology, Nuclear Medicine, and Imaging. Established in 2012, the journal covers the latest breakthroughs and cross-disciplinary approaches that drive innovation in cancer treatment and diagnostics. Although currently classified in the Q4 Quartile for Cancer Research and Q3 for both Oncology and Radiology, Translational Cancer Research continuously works toward improving its academic influence and impact, evidenced by its ongoing research contributions. The journal emphasizes open access, making crucial research available to a global audience. We invite scholars and industry professionals to engage with the latest findings and discussions within these critical areas of medical science.

The Journal of Orthopaedic Translation is a leading peer-reviewed publication dedicated to advancing the field of orthopedics through innovative research and clinical implications. Published by Elsevier and available as an Open Access journal since 2013, it ensures that cutting-edge insights and findings are accessible to a global audience, promoting collaboration and knowledge sharing among researchers, professionals, and students. With an impressive impact factor, the journal has achieved a remarkable Q1 ranking in the categories of Orthopedics and Sports Medicine, placing it in the top 1% of journals in this highly specialized field. As of 2023, it ranks #5 out of 321 in conjunction with a notable 98th percentile achievement in Scopus Ranks, underscoring its reputation for excellence and relevance. Through a focus on both basic and applied research, the Journal of Orthopaedic Translation aims to bridge the gap between laboratory and clinical practice, contributing significantly to the evolving landscape of orthopedic health. Join us in exploring the transformative studies shaping the future of patient outcomes and surgical interventions.

FASEB JOURNAL, published by Wiley, stands as a leading interdisciplinary platform in the realm of biological sciences, prominently featured in the United States. With an impressive 2023 impact factor placing it in the Q1 category across various fields including Biochemistry, Biotechnology, Genetics, Molecular Biology, and Medicine (miscellaneous), the journal is recognized for its substantial contribution to advancing knowledge and innovation. It serves as a vital resource for researchers, professionals, and students alike, providing high-quality, peer-reviewed articles that explore the molecular and cellular mechanisms underlying health and disease. The FASEB JOURNAL not only emphasizes accessible scientific communication but also fosters collaboration within these dynamic fields, making it an essential publication for anyone engaged in cutting-edge life sciences research. To explore more about the journal's offerings and access its vast repository of scholarly articles, visit their official page.

Photodiagnosis and Photodynamic Therapy is a leading journal published by Elsevier, specializing in the fields of biophysics, dermatology, oncology, and pharmacology. With an impressive Q2 ranking across multiple categories in the 2023 category quartiles, this journal is pivotal for researchers and practitioners aiming to advance their knowledge and expertise in photodiagnostic and therapeutic techniques. Since its inception in 2004, it has provided a critical platform for peer-reviewed articles exploring the latest advancements and applications in light-based treatments. As of 2024, the journal will be fully Open Access, enhancing its accessibility and reach across the scientific community. Located in Amsterdam, Netherlands, this journal's commitment to fostering innovation and collaboration makes it an essential resource for those interested in the intersection of light-based technologies and medicine. With its high visibility in key indexed databases like Scopus, researchers can trust that their contributions will be well-regarded and widely disseminated.

Journal of Oral & Facial Pain and Headache is a leading peer-reviewed publication dedicated to advancing the understanding and treatment of orofacial pain and headache disorders. Published by QUINTESSENCE PUBLISHING CO INC in the United States, this journal serves as a critical resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and dentistry. With a commendable impact factor reflected in its 2023 rankings—Q1 in Dental (miscellaneous) and Q2 in both Anesthesiology & Pain Medicine and Clinical Neurology—this journal highlights cutting-edge research and innovative practices aimed at improving patient outcomes. The journal's content is accessible with an Open Access option, ensuring that significant findings reach a broad audience. Since its inception in 1993 and through its evolving scope, Journal of Oral & Facial Pain and Headache remains an indispensable platform for scholarly exchange and professional development in its specialized field.

JOURNAL OF MOLECULAR MEDICINE (JMM) is a premier publication dedicated to advancing the field of molecular medicine, encompassing critical areas such as drug discovery, genetics, and biochemistry. Published by Springer Heidelberg in Germany, this influential journal has established its significance within the academic community, achieving an impressive Q1 ranking across multiple categories as of 2023, including Drug Discovery, Clinical Genetics, and Molecular Medicine. With a focus on publishing high-quality research and novel insights, JMM appeals to a diverse audience of researchers, professionals, and students passionate about the molecular underpinnings of health and disease. The journal, which has seen a convergence of relevant research spanning from 1976 to 2024, is instrumental in showcasing groundbreaking studies that push the boundaries of knowledge in molecular therapeutics and biomedical science. While it does not offer open access, the rigor of its peer-reviewed content ensures that each publication is a valuable addition to the scientific discourse surrounding molecular medicine. For comprehensive studies and reviews that highlight the intersection of molecular biology and clinical application, look no further than JOURNAL OF MOLECULAR MEDICINE.

The Journal of Cosmetic and Laser Therapy, published by TAYLOR & FRANCIS INC in the United Kingdom, serves as a vital resource for professionals, researchers, and students in the fields of dermatology, surgery, and cosmetic medicine. Since its inception in 1999, this peer-reviewed journal has sought to advance knowledge and practice in the burgeoning fields of cosmetic and laser treatments, offering a platform for scholarly articles that explore novel techniques, clinical outcomes, and emerging trends. With an impressive categorization in the 2023 Quartiles showcasing its influence—Q3 in Dermatology and Medicine, and Q2 in Surgery—the journal reflects a commendable impact within the community. Although not an Open Access journal, it provides access to essential information and rigorous research that aids in the development and refinement of treatment protocols. The Scopus ranks further emphasize its significance, particularly in Medicine and Surgery, where it holds positions in the 57th and 52nd percentiles respectively—underscoring its commitment to quality and relevance. As the landscape of cosmetic treatments continues to evolve, the Journal of Cosmetic and Laser Therapy remains an indispensable reference for those looking to stay at the forefront of advancements in this dynamic field.

Photochemistry and Photobiology is a premier journal published by Wiley, dedicated to advancing the field of photochemistry and its applications in biology. With a long-standing history since its inception in 1962, this journal is recognized for its significant contribution to the understanding of light-driven processes, encompassing areas such as biochemistry, medicine, and theoretical chemistry. As evidenced by its impressive Q2 rankings in several categories, including Biochemistry and Physical and Theoretical Chemistry, Photochemistry and Photobiology is an influential resource for researchers and professionals worldwide. The journal's commitment to high-quality research is reflected in its solid standing within important Scopus ranks, marking it as a vital outlet for innovative studies that elucidate the roles of photochemical reactions in biological systems. While it operates on a traditional model rather than Open Access, the journal remains a crucial platform for exchanging knowledge and fostering collaborations across these interconnected disciplines. Explore the latest findings and contribute to the growing body of knowledge in this dynamic field.